Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements (Tables)

v3.20.2
Collaboration and Research Arrangements (Tables)
9 Months Ended
Sep. 30, 2020
Collaborative Arrangement Disclosure [Abstract]  
Schedule of Change in Accounts Receivable, Contract Assets and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the nine months ended September 30, 2020 (in thousands):

 

 

Balance at

December

31, 2019

 

 

Additions

 

 

Deductions

 

 

Balance at

September 30, 2020

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables from collaboration partners

 

$

20,000

 

 

$

4,262

 

 

$

24,260

 

 

$

2

 

Unbilled receivables from collaboration partners

 

 

158

 

 

 

5,396

 

 

 

3,244

 

 

 

2,310

 

Total Accounts receivable and contract assets

 

$

20,158

 

 

$

9,658

 

 

$

27,504

 

 

$

2,312

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue - Incyte

 

$

8,378

 

 

$

335

 

 

$

1,200

 

 

$

7,513

 

Deferred revenue - GBT

 

$

20,000

 

 

$

681

 

 

$

2,799

 

 

$

17,882

 

Total contract liabilities

 

$

28,378

 

 

$

1,016

 

 

$

3,999

 

 

$

25,395